Rheumatoid Arthritis (RA)
190
70
74
56
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
19 trials with published results (10%)
Research Maturity
56 completed trials (29% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
5.8%
11 terminated out of 190 trials
83.6%
-3.0% vs benchmark
14%
27 trials in Phase 3/4
34%
19 of 56 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 56 completed trials
Clinical Trials (190)
Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional, Non-Academic Study
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Impact of Optimised Protein Intake on Household Work Limitations and Disability in Rheumatoid Arthritis
A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)
The Effect of Nicorandil on Rheumatoid Arthritis Patients
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life)
Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis
The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Dysphagia in Rheumatoid Arthritis
Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
the Effect of Ginkgo Biloba on Rheumatoid Arthritis Patients
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis
Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy
Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
Comparison of Oral Administration of a JAK Inhibitor in Rheumatoid Arthritis